Chih-Wei Hsu

Chih-Wei Hsu

Auto-generated profile, based on publicly available information

Chih-Wei Hsu

Department of Integrative Physiology, Baylor College of Medicine, Houston, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
PCPilar Cacheiro
Pilar Cacheiro
VMVioleta Muñoz-Fuentes
Violeta Muñoz-Fuentes
SMStephen A. Murray
Stephen A. Murray
MDMary E. Dickinson
Mary E. Dickinson
MBMaja Bucan
Maja Bucan
DSDamian Smedley
Damian Smedley
The identification of causal variants in sequencing studies remains a considerable challenge that can be partially addressed by new gene-specific knowledge. Here, we integrate measures of how essential a gene is to supporting life, as inferred from viability and phenotyping screens performed on knockout mice by the International Mouse Phenotyping Consortium and essentiality screens carried out on human cell lines. We propose a cross-species gene classification across theFullSpectrum ofIntolerance toLoss-of-function (FUSIL) and demonstrate that genes in five mutually exclusive FUSIL categories have differing biological properties. Most notably, Mendelian disease genes, particularly those associated with developmental disorders, are highly overrepresented among genes non-essential for cell survival but required for organism development. After screening developmental disorder cases from three independent disease sequencing consortia, we identify potentially pathogenic variants in genes not previously associated with rare diseases. We therefore propose FUSIL as an efficient approach for disease gene discovery.

11 October 2022 in eLife
Verified
Journal Article
Open access
CHChih-Wei Hsu
Chih-Wei Hsu
JCJuan Cerda
Juan Cerda
JKJason M Kirk
Jason M Kirk
WTWilliamson D Turner
Williamson D Turner
TRTara L Rasmussen
Tara L Rasmussen
JWJoshua Wythe
Joshua Wythe
Tissue clearing for whole organ cell profiling has revolutionized biology and imaging for exploration of organs in three-dimensional space without compromising tissue architecture. But complicated, laborious procedures, or expensive equipment, as well as the use of hazardous, organic solvents prevent the widespread adoption of these methods. Here, we report a simple and rapid tissue clearing method, EZ Clear, that can clear whole adult mouse organs in 48 hr in just three simple steps. Samples stay at room temperature and remain hydrated throughout the clearing process, preserving endogenous and synthetic fluorescence, without altering sample size. After wholemount clearing and imaging, samples processed with EZ Clear can be subjected to downstream applications, such as tissue embedding and cryosectioning followed by standard histology or immunofluorescent staining without loss of fluorescence signal from endogenous or synthetic reporters. Furthermore, we demonstrate that wholemount adult mouse brains processed with EZ Clear can be successfully immunolabeled for fluorescent imaging while still retaining signal from endogenous fluorescent reporters. Overall, the simplicity, speed, and flexibility of EZ Clear make it easy to adapt and implement in diverse imaging modalities in biomedical research.

17 February 2022 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
NSNadine Spielmann
Nadine Spielmann
GMGregor Miller
Gregor Miller
TOTudor I. Oprea
Tudor I. Oprea
CHChih-Wei Hsu
Chih-Wei Hsu
GFGisela Fobo
Gisela Fobo
MAMartin M. Hrabě de Angelis
Martin M. Hrabě de Angelis
Clinical presentation of congenital heart disease is heterogeneous, making identification of the disease-causing genes and their genetic pathways and mechanisms of action challenging. By using in vivo electrocardiography, transthoracic echocardiography and microcomputed tomography imaging to screen 3,894 single-gene-null mouse lines for structural and functional cardiac abnormalities, here we identify 705 lines with cardiac arrhythmia, myocardial hypertrophy and/or ventricular dilation. Among these 705 genes, 486 have not been previously associated with cardiac dysfunction in humans, and some of them represent variants of unknown relevance (VUR). Mice with mutations inCasz1,Dnajc18,Pde4dip,Rnf38orTmem161bgenes show developmental cardiac structural abnormalities, with their human orthologs being categorized as VUR. Using UK Biobank data, we validate the importance of theDNAJC18gene for cardiac homeostasis by showing that its loss of function is associated with altered left ventricular systolic function. Our results identify hundreds of previously unappreciated genes with potential function in congenital heart disease and suggest causal function of five VUR in congenital heart disease.

4 May 2024 in STAR Protocols
Verified
Journal Article
Open access
TATaeyong Ahn
Taeyong Ahn
GLGabrielle E. Largoza
Gabrielle E. Largoza
JYJulia Younis
Julia Younis
MDMary E. Dickinson
Mary E. Dickinson
CHChih-Wei Hsu
Chih-Wei Hsu
JWJoshua Wythe
Joshua Wythe
Tissue clearing is an essential prerequisite for 3D volumetric imaging of larger tissues or organs. Here, we present a detailed protocol for optical, aqueous-based clearing of adult murine tissues using EZ Clear. We describe steps to ensure successful perfusion and fixation of organs from the adult mouse and supply guidelines for optimal lipid removal, refractive index matching, and tissue clearing. Finally, we provide imaging parameters for visualizing both exogenous perfused fluorescent dyes and endogenous fluorescence reporters in the adult mouse. For complete details on the use and execution of this protocol, please refer to Hsu et al.1.

13 June 2019 in Current Protocols in Mouse Biology
Verified
Journal Article
Open access
PDF file
CHChih‐Wei Hsu
Chih‐Wei Hsu
SKSowmya Kalaga
Sowmya Kalaga
UAUchechukwu Akoma
Uchechukwu Akoma
TRTara L. Rasmussen
Tara L. Rasmussen
ACAudrey E. Christiansen
Audrey E. Christiansen
MDMary E. Dickinson
Mary E. Dickinson
Iodine‐contrast micro‐computed tomography (microCT) 3D imaging provides a non‐destructive and high‐throughput platform for studying mouse embryo and neonate development. Here we provide protocols on preparing mouse embryos and neonates between embryonic day 8.5 (E8.5) to postnatal day 4 (P4) for iodine‐contrast microCT imaging. With the implementation of the STABILITY method to create a polymer‐tissue hybrid structure, we have demonstrated that not only is soft tissue shrinkage minimized but also the minimum required time for soft tissue staining with iodine is decreased, especially for E18.5 to P4 samples. In addition, we also provide a protocol on using commercially available X‐CLARITYTM hydrogel solution to create the similar polymer‐tissue hybrid structure on delicate early post‐implantation stage (E8.5 to E14.5) embryos. With its simple sample staining and mounting processes, this protocol is easy to adopt and implement for most of the commercially available, stand‐alone microCT systems in order to study mouse development between early post‐implantation to early postnatal stages. © 2019 by John Wiley & Sons, Inc.

3 August 2020 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
BSBridget M Stroup
Bridget M Stroup
RMRonit Marom
Ronit Marom
XLXiaohui Li
Xiaohui Li
CHChih-Wei Hsu
Chih-Wei Hsu
CCCheng-Yen Chang
Cheng-Yen Chang
LBLindsay C Burrage
Lindsay C Burrage
Lysinuric protein intolerance (LPI) is an inborn error of cationic amino acid (arginine, lysine, ornithine) transport caused by biallelic pathogenic variants in SLC7A7, which encodes the light subunit of the y+LAT1 transporter. Treatments for the complications of LPI, including growth failure, renal disease, pulmonary alveolar proteinosis, autoimmune disorders and osteoporosis, are limited. Given the early lethality of the only published global Slc7a7 knockout mouse model, a viable animal model to investigate global SLC7A7 deficiency is needed. Hence, we generated two mouse models with global Slc7a7 deficiency (Slc7a7em1Lbu/em1Lbu; Slc7a7Lbu/Lbu and Slc7a7em1(IMPC)Bay/em1(IMPC)Bay; Slc7a7Bay/Bay) using CRISPR/Cas9 technology by introducing a deletion of exons 3 and 4. Perinatal lethality was observed in Slc7a7Lbu/Lbu and Slc7a7Bay/Bay mice on the C57BL/6 and C57BL/6NJ inbred genetic backgrounds, respectively. We noted improved survival of Slc7a7Lbu/Lbu mice on the 129 Sv/Ev × C57BL/6 F2 background, but postnatal growth failure occurred. Consistent with human LPI, these Slc7a7Lbu/Lbu mice exhibited reduced plasma and increased urinary concentrations of the cationic amino acids. Histopathological assessment revealed loss of brush border and lipid vacuolation in the renal cortex of Slc7a7Lbu/Lbu mice, which combined with aminoaciduria suggests proximal tubular dysfunction. Micro-computed tomography of L4 vertebrae and skeletal radiographs showed delayed skeletal development and suggested decreased mineralization in Slc7a7Lbu/Lbu mice, respectively. In addition to delayed skeletal development and delayed development in the kidneys, the lungs and liver were observed based on histopathological assessment. Overall, our Slc7a7Lbu/Lbu mouse model on the F2 mixed background recapitulates multiple human LPI phenotypes and may be useful for future studies of LPI pathology.